Glen Harbor Capital Management’s Syndax Pharmaceuticals SNDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q3 | $21K | Hold |
2,816
| – | – | ﹤0.01% | 1296 |
|
|
2019
Q2 | $26K | Hold |
2,816
| – | – | ﹤0.01% | 1288 |
|
|
2019
Q1 | $15K | Sell |
2,816
-550
| -16% | -$2.93K | ﹤0.01% | 1286 |
|
|
2018
Q4 | $15K | Buy |
+3,366
| New | +$15K | ﹤0.01% | 1253 |
|
|
2018
Q3 | – | Sell |
-37,444
| Closed | -$263K | – | 1293 |
|
|
2018
Q2 | $263K | Buy |
37,444
+1,870
| +5% | +$13.1K | 0.01% | 883 |
|
|
2018
Q1 | $506K | Hold |
35,574
| – | – | 0.01% | 634 |
|
|
2017
Q4 | $312K | Sell |
35,574
-3,938
| -10% | -$34.5K | 0.01% | 815 |
|
|
2017
Q3 | $462K | Buy |
39,512
+2,486
| +7% | +$29.1K | 0.01% | 619 |
|
|
2017
Q2 | $517K | Buy |
37,026
+14,696
| +66% | +$205K | 0.01% | 588 |
|
|
2017
Q1 | $306K | Hold |
22,330
| – | – | 0.01% | 661 |
|
|
2016
Q4 | $160K | Buy |
+22,330
| New | +$160K | ﹤0.01% | 754 |
|